MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
issuance of common stock,...
$19,089K
Cash acquired in
envue merger
$148K
Proceeds from issuance of
notes payable to...
$1,300K
Proceeds from issuance of
short-term loan payable
$360K
Proceeds from exercise of
warrants
$102K
Other
$12K
Net cash provided by
financing activities
$12,786K
Net cash provided by
(used in) investing...
$88K
Canceled cashflow
$8,077K
Canceled cashflow
$60K
Net increase in
cash, cash...
$3,502K
Canceled cashflow
$9,372K
Repurchase of series x
preferred stock
$5,000K
Payments of short-term
loan to related party
$1,777K
Payments of note payable
to related party
$1,300K
Impairment of goodwill and
long-lived assets
$11,154K
Issuance cost allocated
to warrant...
$1,420K
Other accounts
payable and accrued...
$1,025K
Depreciation and
amortization
$897K
Trade payables
$552K
Inventory
-$249K
Noncash interest
expense
$239K
Deferred revenue
$160K
Operating right of use
asset
-$71K
Other
$19K
Purchase of property
plant and equipment
$60K
Net cash used in
operating activities
-$9,372K
Canceled cashflow
$15,786K
Net loss
-$18,185K
Change in fair value of
warrant liability
$6,204K
Changes in deferred
income taxes, net
-$373K
Trade receivable
$179K
Prepaid expenses and
other accounts...
$96K
Operating lease
liabilities
-$85K
Accrued severance pay,
net
-$36K
Back
Back
Cash Flow
source: myfinsight.com
ENvue Medical, Inc. (FEED)
ENvue Medical, Inc. (FEED)